Inhibition by (±)-indenestrol A of interferon gamma-stimulated nitric oxide formation in murine macrophage RAW 264.7 cells

Mutation Research - Genetic Toxicology and Environmental Mutagenesis

Volumn 534, Issue 1-2, 2003, Pages 187-195

  Oda, Taiko ^a   So, You ^a   Sato, Yoshihiro ^a   Shimizu, Noriaki ^b   Handa, Hiroshi ^b   Yasukochi, Yukio ^c   Kasahara, Tadashi ^a  

^a KEIO UNIVERSITY   (Japan)

^b TOKYO INSTITUTE OF TECHNOLOGY   (Japan)

^c TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

Apoptosis; IFN ; Indenestrol A; Nitric oxide; RAW 264.7

Indexed keywords

DIETHYLSTILBESTROL; GAMMA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDENESTROL A; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; TRANSCRIPTION FACTOR; ESTROGEN; INDENE DERIVATIVE; INDENESTROL; INDUCIBLE NITRIC OXIDE SYNTHASE; NOS2 PROTEIN, MOUSE;

ANIMAL CELL; APOPTOSIS; ARTICLE; BIOASSAY; CARCINOGENESIS; CONTROLLED STUDY; DRUG EFFECT; DRUG INHIBITION; GENE REPRESSION; IN VITRO STUDY; MACROPHAGE; NONHUMAN; ONSET AGE; PRIORITY JOURNAL; STAINING; STIMULATION; WESTERN BLOTTING; ANIMAL; CELL CULTURE; ENZYME ACTIVATION; GENETIC TRANSCRIPTION; GENETICS; METABOLISM; MOUSE; PATHOLOGY; PHYSIOLOGY;

MURINAE;

ANIMALS; APOPTOSIS; CELLS, CULTURED; DIETHYLSTILBESTROL; ENZYME ACTIVATION; ESTROGENS, NON-STEROIDAL; INDENES; INTERFERON TYPE II; MACROPHAGES; MICE; NF-KAPPA B; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; TRANSCRIPTION, GENETIC;

EID: 0037427885     PISSN: 13835718     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1383-5718(02)00275-9     Document Type: Article

References (33)

1. J.H. Clark Jr., E.J. Peck, Female Sex Steroid Receptors and Function, Springer/Verlag, New York, 1979.
2. Marselos M., Tomatis L. Diethylstilbestrol: I. Pharmacology, toxicology and carcinogenicity in humans. Eur. J. Cancer. 28A:1992;1182-1189.
3. Gottschlich R., Metzler M. Metabolic fate of diethylstilbestrol in the syrian hamster, a susceptible species for diethylstilboestrol carcinogenicity. Xenobiotica. 10:1980;317-327.
4. Degen G.H., Metzler M. Indanyl analogs of diethylstilbestrol: differential interaction with prostaglandin H synthase. Carcinogenesis. 10:1989;839-845.
5. Brune B., von Knethen A., Sandau K.B. Nitric oxide and its role in apoptosis. Eur. J. Pharmacol. 351:1998;172-261.
6. Messmer U.K., Lapetina E.G., Brune B. Nitric oxide-induced apoptosis in RAW 264.7 macrophages is antagonized by protein kinase C- and protein kinase A-activating compounds. Mol. Pharmacol. 47:1995;757-765.
7. Albina J.E., Cui S., Mateo R.B., Reichner J.S. Nitric oxide-mediated apoptosis in murine peritoneal macrophages. J. Immunol. 150:1993;5080-5085.
8. Sarih M., Souvannavong V., Adam A. Nitric oxide synthase induces macrophage death by apoptosis. Biochem. Biophys. Res. Commun. 191:1993;503-508.
9. von Brune B., Knethen A., Sandau K.B. Nitric oxide and its role in apoptosis. Eur. J. Pharmacol. 351:1995;261-272.
10. Fehsel K., Kroncke K.D., Meyer K.L., Huber H., Wahn V., Kolb-Bachofen V. Nitric oxide induces apoptosis in mouse thymocytes. J. Immunol. 155:1995;2858-2865.
11. von Glockzin S., Knethen A., Scheffner M., Brune B. Activation of the cell death program by nitric oxide involves inhibition of the proteasome. J. Biol. Chem. 274:1999;19581-19586.
12. Miller L., Ally E.W., Murphy W.J., Russell S.W., Hunt J.S. Progesterone inhibits inducible nitric oxide synthase gene expression and nitric oxide production in murine macrophages. J. Leukoc. Biol. 59:1996;442-450.
13. Hayashi T., Yamada K., Esaki T., Mutoh E., Iguchi A. Effect of estrogen on isoforms of nitric oxide synthase possible mechanism of anti-atherosclerotic effect of estrogen. Gerontology. 43:1997;24-34.
14. Buzard G.S., Kasprzak K.S. Possible roles of nitric oxide and redox cell signaling in toxicity and carcinogenesis: a review. J. Environ. Pathol. Toxicol. Oncol. 19:2000;179-199.
15. Oda T., Sakakibara Y., Sato Y., Hanzawa H., Hata T. Effects of (+)-, (-)- and (±)-indenestrols A and B on microtubule polymerization. Chem. Pharm. Bull. 40:1992;588-592.
16. Oda T., Kasahara T., Matsuura M., Mukaida N. Nitric oxide-mediated modulation of interleukin-8 production by a human glioblastoma cell line, T98G, cocultured with myeloid and monocytic cell lines. J. Interferon Cytokine Res. 18:1998;905-912.
17. Kojima H., Sakurai K., Kikuchi K., Kawahara S., Kirino Y., Nagoshi H., Hirata Y., Nagano T. Development of a fluorescent indicator for nitric oxide based on the fluorescein chromophore. Chem. Pharm. Bull. 46:1998;373-375.
18. Shimizu S., Nomoto M., Naito S., Yamamoto T., Momose K. Stimulation of nitric oxide synthase during oxidative endothelial cell injury. Biochem. Pharmacol. 55:1998;77-83.
19. Carmichael J., DeGraff W.G., Gazdar A.F., Minna J.D., Mitchell J.B. Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of radiosensitivity. Cancer Res. 47:1987;939-942.
20. Sellins K.S., Cohen J.J. Gene induction by gamma-irradiation leads to DNA fragmentation in lymphocytes. J. Immunol. 139:1987;3199-3206.
21. Hiramoto M., Shimizu N., Sugimoto K., Tang J., Kawakami Y., Ito M., Aizawa S., Tanaka H., Makino I., Handa H. Nuclear targeted suppression of NF-κB activity by the novel quinone derivative E3330. J. Immunol. 160:1998;810-819.
22. Inagaki H., Matsushima Y., Ohshima M., Kitagawa Y. Interferons suppress mitochondrial gene transcription by depleting mitochondrial transcription factor A [mtTFA]. J. Interferon Cytokine Res. 17:1997;263-269.
23. Shuai K., Horvath C.M., Huang L.H., Qureshi S.A., Cowburn D., Darnell J.E. Jr. Interferon activation of the transcription factor stat 1 involves dimerization through SH2-phosphotyrosyl peptide interactions. Cell. 76:1994;821-828.
24. T. Oda, M. Kaneko, Formation of active oxygen species from diethylstilbestrol, a synthetic estrogen: Its metabolite in the presence of RAW 264.7 cells, Biol. Pharm. Bull., in press.
25. Mathur S., Mathur R.S., Goust J.M., Williamson H.O., Fudenberg H.H. Sex steroid hormones and circulating IgE levels. Clin. Exp. Immunol. 30:1977;403-407.
26. Forsberg J.G. Short-term and long-term effects of estrogen on lymphoid tissues and lymphoid cells with some remarks on the significance for carcinogenesis. Arch. Toxicol. 55:1984;79-90.
27. Polan M.L., Daniele A., Kuo A. Gonadal steroids modulate human monocyte interleukin-1 (IL-1) activity. Fertil. Steril. 49:1988;964-968.
28. Mori H., Nakagawa M., Itoh N., Wada K., Tamaya T. Danazol suppresses the production of interleukin-1 beta and tumor necrosis factor by human monocytes. Am. J. Reprod. Immunol. 24:1990;45-50.
29. Grossman C.J., Roselle G.A., Mendenhall C.L. Sex steroid regulation of autoimmunity. J. Steroid. Biochem. Mol. Biol. 40:1991;649-659.
30. Fujimoto J., Hori M., Itoh T., Ichigo S., Nishigaki M., Tamaya T. Danazol decreases transcription of estrogen receptor gene in human monocytes. Gen. Pharmacol. 26:1995;507-516.
31. Olsen N.J., Kovacs W.J. Gonadal steroids and immunity. Endocr. Rev. 17:1996;369-384.
32. Wright S.C., Zhong J., Larrick J.W. Inhibition of apoptosis as a mechanism of tumor promotion. FASEB J. 8:1994;654-660.
33. Kodama M., Inoue F., Kaneko M., Oda T., Sato Y. Formation of free radicals and active oxygen species from diethylstilbestrol and its derivatives. Anticancer Res. 13:1993;1209-1213.